Evidence map›Paper›PMID 41766623›Full record

ArticlePlant physiology2026

Deciphering the metabolic details of L-lysine toxicity in cyanobacteria.

Andreas M Enkerlin, Ute A Hoffmann, Johanna Rapp, Rui Miao, Johannes Postma, Michael Feldbrügge, Hannes Link, Elton P Hudson, Khaled A Selim

Abstract read
In one paragraph

Article in Plant physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Focus on algae and aquatic plants.Plant physiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Andreas M EnkerlinMicrobial Biochemistry Group, Institute of Phototrophic Microbiology, CEPLAS Cluster of Excellence, Heinrich-Heine University Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany.ORCID 0000-0001-6990-820X
Ute A HoffmannSchool of Engineering Sciences in Chemistry, Biotechnology and Health, Science for Life Laboratory, KTH-Royal Institute of Technology, Stockholm SE-17165, Sweden.ORCID 0000-0002-9658-2695
Johanna RappBacterial Metabolomics, Interfaculty Institute of Microbiology and Infection Medicine Tübingen and Cluster of Excellence "Controlling Microbes to Fight Infections", Tübingen University, Tübingen, Germany.ORCID 0000-0002-4591-8312
Rui MiaoSchool of Engineering Sciences in Chemistry, Biotechnology and Health, Science for Life Laboratory, KTH-Royal Institute of Technology, Stockholm SE-17165, Sweden.ORCID 0000-0003-2911-6886
Johannes PostmaInstitute of Microbiology, Heinrich-Heine University Düsseldorf, Universitätsstr. 1, Düsseldorf 40225, Germany.ORCID 0009-0002-0565-4487
Michael FeldbrüggeInstitute of Microbiology, Heinrich-Heine University Düsseldorf, Universitätsstr. 1, Düsseldorf 40225, Germany.ORCID 0000-0003-0046-983X
Hannes LinkBacterial Metabolomics, Interfaculty Institute of Microbiology and Infection Medicine Tübingen and Cluster of Excellence "Controlling Microbes to Fight Infections", Tübingen University, Tübingen, Germany.
Elton P HudsonSchool of Engineering Sciences in Chemistry, Biotechnology and Health, Science for Life Laboratory, KTH-Royal Institute of Technology, Stockholm SE-17165, Sweden.ORCID 0000-0003-1899-7649
Khaled A SelimMicrobial Biochemistry Group, Institute of Phototrophic Microbiology, CEPLAS Cluster of Excellence, Heinrich-Heine University Düsseldorf, Universitätsstraße 1, 40225 Düsseldorf, Germany.ORCID 0000-0002-2974-9483

Funding

Controlling Microbes to Fight Infections EXC2124-390838134Emmy Noether SE 3449/3-1German Federal and Baden-Württemberg StateGerman Research Foundation SPP2389Novo Nordisk Foundation NNF20OC0061469School Molecules of Infection
6 · The paper itself

Abstract

L-lysine (Lys) has been explored as a potential cyanobactericide due to its inhibitory effects on cyanobacterial growth at micromolar concentrations, comparable to many antibiotics. Here, we investigated the early metabolic and physiological responses of the model cyanobacterium Synechocystis sp. PCC 6803 to Lys exposure. Physiological analyses revealed cell enlargement, oxidative stress, and photosynthesis inhibition, leading to growth arrest. Metabolomic profiling indicated disruptions in peptidoglycan biosynthesis, evidenced by the accumulation of L-/D-alanine, meso-diaminopimelate, and D-Ala-D-Ala, suggesting interference with cell wall integrity. Furthermore, levels of energy metabolites and other amino acids, including tyrosine, tryptophan, valine, and iso-/leucine, were significantly altered, implying broader metabolic impacts of Lys toxicity. To explore potential resistance mechanisms, we used a CRISPRi-based genetic screen to identify key genes involved in relieving Lys toxicity. The Bgt permease system, responsible for basic amino acid uptake, was essential for acquiring Lys resistance, as a bgtA mutant exhibited normal growth on elevated Lys concentrations, thereby validating our CRISPRi screen. Additionally, UirR, a DNA-binding response regulator, and genes linked to c-di-AMP signaling seemed implicated in Lys metabolism. Deletion of the c-di-AMP synthase gene increased Lys sensitivity, supporting a role for c-di-AMP in cell wall homeostasis and osmotic stress regulation. Altogether, our findings explored the early metabolic responses and physiological consequences of Lys exposure in Synechocystis, demonstrating its effects on peptidoglycan biosynthesis, amino acid metabolism, and nucleotide biosynthesis. This, as well as the identification of key genetic factors contributing to Lys resistance, provides insights into cyanobacterial physiology and the potential application of Lys in bloom-control strategies.

Indexed as

LysineSynechocystisAmino AcidsBacterial ProteinsCell WallOxidative StressPeptidoglycanPhotosynthesisAmino AcidsBacterial ProteinsLysinePeptidoglycan

Identifiers

PMID41766623
PMCPMC13130207

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.